Australia, June 4 -- DECIPHERA PHARMACEUTICALS LLC, owns the trademark (2514997) for 'ROMVIMZA' and '4 CHEVRONS' till Jan. 20, 2035.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biologica...